Dignify Therapeutics
Signal active
Organization
Contact Information
Overview
Dignify Therapeutics is a drug development company focused on delivering novel drug therapies for bladder and bowel disorders in spinal cord injured, multiple sclerosis and similar patient populations. By combining novel pharmaceutical agents with drug delivery technology, Dignify Therapeutics will redefine the treatment of these disorders and restore the dignity of voluntary excretory function for these patients.
The company was founded in 2013 and is headquartered in Raleigh, North Carolina.
About
Industries
Biotechnology, Health Care, Pharmaceutical, Therapeutics
Founded
2013
Employees
1-10
Headquarters locations
Raleigh, North Carolina, United States, North America
Social
Profile Resume
Dignify Therapeutics headquartered in United States, North America, operates in the Biotechnology, Health Care, Pharmaceutical, Therapeutics sector. The company focuses on Biotechnology and has secured $975.3M in funding across 96 round(s). With a team of 1-10 employees, Dignify Therapeutics is actively contributing to advancements in Biotechnology. Their latest funding round, Debt Financing - Dignify Therapeutics, raised $50.0K. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
Funding rounds
6
Investors
0
Lead Investors
0
Total Funding Amount
$10.2M
Details
0
Dignify Therapeutics has raised a total of $10.2M in funding over 0 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|
Investors
Dignify Therapeutics is funded by 9 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| Dignify Therapeutics | - | FUNDING ROUND - Dignify Therapeutics | 3.0M |
| Terry Engle | - | FUNDING ROUND - Terry Engle | 3.0M |
| Dignify Therapeutics | - | FUNDING ROUND - Dignify Therapeutics | 159.0K |
| National Institutes of Health | - | FUNDING ROUND - National Institutes of Health | 159.0K |
Recent Activity
News
Apr 18, 2024
The Business Journals - Execs forgo salaries as D.C. inaction continues on Section 174
News
Mar 20, 2024
The Business Journals - Former public company CEO now leads RTP firm - Triangle Business Journal
News
Mar 18, 2024
BioSpace - Dignify Therapeutics Announces Anthony DiTonno as Chief Executive Officer
Funding Round
Mar 01, 2019
Dignify Therapeutics raised $3600000 on 2019-03-01 in Grant
Funding Round
Oct 12, 2016
Dignify Therapeutics raised $3100000 on 2016-10-12 in Grant
Funding Round
Feb 04, 2015
Dignify Therapeutics raised $3000000 on 2015-02-04 in Venture Round